Bindu Edwin, NP
Nurse Practitioner · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · El Camino Health Medical Network LLC · 202 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Bindu Edwin’s office at (408) 871-3400 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$39,784
Medicare paid this office $39,784 for 278 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 110 | $13,215 | $94 |
| Short return visit (20+ min) | 121 | $8,944 | $60 |
| Long return visit (40+ min) | 56 | $8,173 | $128 |
| New patient visit (30+ min) | 27 | $1,801 | $67 |
| New patient visit (15+ min) | 12 | $560 | $47 |
See all 7 services
| Return visit (30+ min) | 110 | $13,215 | $94 |
| Short return visit (20+ min) | 121 | $8,944 | $60 |
| Long return visit (40+ min) | 56 | $8,173 | $128 |
| New patient visit (30+ min) | 27 | $1,801 | $67 |
| New patient visit (15+ min) | 12 | $560 | $47 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $156 | $10 |
| Urinalysis, manual test | 17 | $82 | $3 |
Who their Medicare patients are
278 Original Medicare patients in 2024. Average age 77 · Women 78% · Also on Medicaid 11% · Health risk score 1.10. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 26% · Coronary heart disease 24% · Depression 21% · Chronic kidney disease 20% · Heart failure 15% · Atrial fibrillation 15% · Cancer 12% · COPD 12% · Dementia 9% · Stroke 9%.
The office billed $198,456, Medicare allowed $56,270 and paid $39,784; for 532 services of 30 kinds; $2,250 of it was for drugs given in the office and $37,534 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 278 | 532 | 77 | 1.10 | $198,456 | $39,784 |
| 2023 | 308 | 528 | 76 | 1.24 | $204,276 | $42,284 |
| 2022 | 150 | 252 | 76 | 1.10 | $83,522 | $19,092 |
| 2021 | 80 | 162 | 75 | 2.15 | $25,523 | $10,213 |
| 2020 | 254 | 756 | 72 | 2.92 | $81,794 | $39,924 |
| 2019 | 257 | 706 | 67 | 2.51 | $62,594 | $27,625 |
| 2018 | 97 | 235 | 66 | 1.58 | $20,852 | $9,092 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Return visit (30+ min) | 132 | $15,941 | $98 |
| Long return visit (40+ min) | 47 | $7,509 | $147 |
| Short return visit (20+ min) | 103 | $6,728 | $59 |
| New patient visit (45+ min) | 33 | $3,970 | $120 |
| New patient visit (30+ min) | 41 | $2,766 | $67 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $2,034 | $136 |
| Influenza vaccine split virus, preservative free | 13 | $935 | $72 |
| Administration of influenza virus vaccine | 14 | $450 | $32 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $160 | $12 |
| Urinalysis, manual test | 22 | $78 | $3 |
2022: 7 services
| Return visit (30+ min) | 45 | $5,933 | $106 |
| Short return visit (20+ min) | 50 | $3,548 | $70 |
| New patient visit (45+ min) | 16 | $1,982 | $124 |
| New patient visit (30+ min) | 16 | $1,523 | $95 |
| Short return visit | 25 | $1,089 | $42 |
| New patient visit (15+ min) | 14 | $812 | $58 |
| Administration of influenza virus vaccine | 12 | $386 | $32 |
2021: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $4,128 | $51 |
| Short return visit (20+ min) | 23 | $1,902 | $76 |
| Return visit (30+ min) | 11 | $1,160 | $105 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,053 | $75 |
2020: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 165 | $24,244 | $52 |
| Hospital discharge day management, more than 30 minutes | 79 | $6,521 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $4,520 | $75 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 23 | $1,223 | $28 |
| Return visit (30+ min) | 19 | $928 | $49 |
| Hospital discharge day management, 30 minutes or less | 12 | $631 | $53 |
| Short return visit (20+ min) | 16 | $443 | $23 |
| Insertion of needle into vein for collection of blood sample | 12 | $38 | $3 |
2019: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 97 | $10,432 | $51 |
| Return visit (30+ min) | 78 | $6,059 | $64 |
| Short return visit (20+ min) | 58 | $3,099 | $40 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 48 | $2,482 | $27 |
| Hospital discharge day management, more than 30 minutes | 14 | $1,114 | $74 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,100 | $100 |
| Hospital discharge day management, 30 minutes or less | 16 | $812 | $51 |
| Influenza vaccine split virus, preservative free | 13 | $711 | $55 |
| Short return visit | 13 | $310 | $24 |
| Administration of influenza virus vaccine | 16 | $268 | $17 |
| Insertion of needle into vein for collection of blood sample | 47 | $150 | $3 |
| Blood glucose (sugar) test performed by hand-held instrument | 30 | $119 | $3 |
2018: 5 services
| Return visit (30+ min) | 54 | $4,136 | $63 |
| Short return visit (20+ min) | 37 | $1,885 | $45 |
| Short return visit | 12 | $239 | $20 |
| Insertion of needle into vein for collection of blood sample | 33 | $100 | $3 |
| Blood glucose (sugar) test performed by hand-held instrument | 22 | $83 | $3 |
Drugs they prescribed that Part D paid
$44,977
Pharmacies billed $44,977 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (12 of 1,081) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
958 generic and 107 brand-name prescriptions · $44,977 in drug cost · 117 antibiotic prescriptions to 91 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Breo Ellipta | 14 | $5,588 | $399 |
| Atorvastatin | 55 | $729 | $13 |
| Albuterol Sulfate Hfa | 28 | $691 | $25 |
| Levothyroxine | 48 | $664 | $14 |
| Pantoprazole | 27 | $506 | $19 |
See all 29 drugs
| Breo Ellipta | 14 | $5,588 | $399 |
| Atorvastatin | 55 | $729 | $13 |
| Albuterol Sulfate Hfa | 28 | $691 | $25 |
| Levothyroxine | 48 | $664 | $14 |
| Pantoprazole | 27 | $506 | $19 |
| Metoprolol | 18 | $430 | $24 |
| Rosuvastatin | 20 | $396 | $20 |
| Nitrofurantoin Mono-Macro | 31 | $374 | $12 |
| Diclofenac | 27 | $371 | $14 |
| Losartan | 31 | $369 | $12 |
| Fluticasone Propionate | 22 | $344 | $16 |
| Omeprazole | 25 | $323 | $13 |
| Lisinopril | 24 | $265 | $11 |
| Triamcinolone Acetonide | 29 | $229 | $8 |
| Amlodipine Besylate | 36 | $209 | $6 |
| Gabapentin | 34 | $194 | $6 |
| Metformin Hcl Er | 26 | $165 | $6 |
| Cephalexin | 23 | $165 | $7 |
| Amoxicillin-Clavulanate Potass | 22 | $155 | $7 |
| Simvastatin | 13 | $146 | $11 |
| Hydrochlorothiazide | 15 | $130 | $9 |
| Metformin | 11 | $116 | $11 |
| Methylprednisolone | 13 | $100 | $8 |
| Furosemide | 12 | $83 | $7 |
| Azithromycin | 18 | $65 | $4 |
| Meloxicam | 11 | $61 | $6 |
| Metoprolol | 11 | $55 | $5 |
| Hydrocodone-Acetaminophen | 12 | $49 | $4 |
| Paxlovid | 16 | $0 | $0 |
Year by year
| 2024 | 1,081 | 327 | 1% (12) | 10% | $44,977 |
| 2023 | 882 | 375 | None | 9% | $37,552 |
| 2022 | 344 | 181 | 0% (0) | 8% | $72,571 |
| 2021 | 85 | 43 | None | None | $1,655 |
| 2020 | 637 | 188 | None | None | $36,635 |
| 2019 | 1,952 | 313 | 1% (16) | 18% | $140,069 |
| 2018 | 3,112 | 353 | 2% (54) | 17% | $195,652 |
| 2017 | 19 | None | 0% (0) | None | $2,316 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Diclofenac | 38 | $1,488 | $39 |
| Atorvastatin | 49 | $954 | $19 |
| Albuterol Sulfate Hfa | 19 | $578 | $30 |
| Amlodipine Besylate | 42 | $527 | $13 |
| Levothyroxine | 37 | $470 | $13 |
| Losartan | 27 | $446 | $17 |
| Pantoprazole | 29 | $397 | $14 |
| Nitrofurantoin Mono-Macro | 24 | $367 | $15 |
| Amoxicillin-Clavulanate Potass | 22 | $293 | $13 |
| Paxlovid (Eua) | 27 | $262 | $10 |
| Lisinopril | 29 | $256 | $9 |
| Rosuvastatin | 13 | $246 | $19 |
| Gabapentin | 17 | $197 | $12 |
| Metformin Hcl Er | 18 | $170 | $9 |
| Naproxen | 23 | $169 | $7 |
| Azithromycin | 23 | $126 | $5 |
| Triamcinolone Acetonide | 13 | $121 | $9 |
| Omeprazole | 12 | $106 | $9 |
| Hydrochlorothiazide | 18 | $99 | $5 |
2022: 10 drugs
| Methotrexate | 17 | $332 | $20 |
| Diclofenac | 14 | $256 | $18 |
| Atorvastatin | 15 | $248 | $17 |
| Losartan | 11 | $242 | $22 |
| Pantoprazole | 19 | $161 | $8 |
| Amoxicillin-Clavulanate Potass | 11 | $151 | $14 |
| Paxlovid (Eua) | 15 | $149 | $10 |
| Levothyroxine | 12 | $121 | $10 |
| Azithromycin | 14 | $72 | $5 |
| Meloxicam | 14 | $40 | $3 |
2020: 13 drugs
| Atorvastatin | 31 | $374 | $12 |
| Amlodipine Besylate | 33 | $272 | $8 |
| Metoprolol | 18 | $219 | $12 |
| Losartan | 18 | $183 | $10 |
| Lisinopril | 36 | $180 | $5 |
| Methylprednisolone | 15 | $166 | $11 |
| Pantoprazole | 16 | $150 | $9 |
| Metformin | 16 | $145 | $9 |
| Simvastatin | 15 | $130 | $9 |
| Fluticasone Propionate | 12 | $127 | $11 |
| Furosemide | 20 | $85 | $4 |
| Prednisone | 14 | $46 | $3 |
| Hydrochlorothiazide | 11 | $24 | $2 |
2019: 44 drugs
| Symbicort | 37 | $14,740 | $398 |
| Incruse Ellipta | 32 | $10,729 | $335 |
| Advair Diskus | 13 | $5,458 | $420 |
| Ventolin Hfa | 49 | $3,234 | $66 |
| Albuterol Sulfate Hfa | 39 | $2,056 | $53 |
| Esomeprazole Magnesium | 15 | $1,988 | $133 |
| Atorvastatin | 100 | $1,422 | $14 |
| Metoprolol | 41 | $1,132 | $28 |
| Amlodipine Besylate | 92 | $791 | $9 |
| Levothyroxine | 40 | $772 | $19 |
| Omeprazole | 41 | $702 | $17 |
| Potassium Chloride | 19 | $668 | $35 |
| Lisinopril | 100 | $653 | $7 |
| Alcohol Prep Pads | 13 | $651 | $50 |
| Losartan | 61 | $530 | $9 |
| Pravastatin | 30 | $514 | $17 |
| Clopidogrel | 35 | $462 | $13 |
| Simvastatin | 51 | $422 | $8 |
| Methylprednisolone | 32 | $402 | $13 |
| Cefuroxime | 16 | $399 | $25 |
| Isosorbide Mononitrate Er | 17 | $384 | $23 |
| Metformin | 57 | $372 | $7 |
| Allopurinol | 36 | $366 | $10 |
| Naproxen | 20 | $296 | $15 |
| Fluticasone Propionate | 19 | $275 | $14 |
| Glimepiride | 23 | $271 | $12 |
| Ibuprofen | 30 | $253 | $8 |
| Hydrocodone-Acetaminophen | 13 | $224 | $17 |
| Tamsulosin | 14 | $223 | $16 |
| Famotidine | 20 | $222 | $11 |
| Montelukast | 13 | $211 | $16 |
| Pantoprazole | 24 | $204 | $8 |
| Primidone | 14 | $188 | $13 |
| Amoxicillin-Clavulanate Potass | 21 | $176 | $8 |
| Metoprolol | 26 | $170 | $7 |
| Carvedilol | 11 | $155 | $14 |
| Furosemide | 36 | $154 | $4 |
| Meloxicam | 21 | $123 | $6 |
| Azithromycin | 15 | $102 | $7 |
| Hydrochlorothiazide | 23 | $96 | $4 |
| Ciprofloxacin | 14 | $87 | $6 |
| Amoxicillin | 20 | $79 | $4 |
| Prednisone | 14 | $77 | $6 |
| Fluconazole | 13 | $76 | $6 |
2018: 62 drugs
| Januvia | 25 | $19,078 | $763 |
| Novolog | 19 | $14,402 | $758 |
| Symbicort | 32 | $12,310 | $385 |
| Ventolin Hfa | 126 | $7,961 | $63 |
| Lantus Solostar | 14 | $6,460 | $461 |
| Spiriva | 14 | $5,544 | $396 |
| Incruse Ellipta | 14 | $4,591 | $328 |
| Metoprolol | 63 | $1,427 | $23 |
| Omeprazole | 110 | $1,061 | $10 |
| Levothyroxine | 57 | $1,031 | $18 |
| Pravastatin | 56 | $1,003 | $18 |
| Atorvastatin | 89 | $960 | $11 |
| Lisinopril | 188 | $939 | $5 |
| Gabapentin | 74 | $830 | $11 |
| Potassium Chloride | 35 | $770 | $22 |
| Simvastatin | 71 | $695 | $10 |
| Polyethylene Glycol 3350 | 22 | $692 | $31 |
| Hydrocodone-Acetaminophen | 45 | $669 | $15 |
| Alcohol Prep Pads | 15 | $662 | $44 |
| Amlodipine Besylate | 115 | $659 | $6 |
| Oxybutynin Chloride Er | 16 | $639 | $40 |
| Allopurinol | 39 | $612 | $16 |
| Duloxetine | 22 | $596 | $27 |
| Glimepiride | 52 | $547 | $11 |
| Methylprednisolone | 42 | $512 | $12 |
| Fluticasone Propionate | 44 | $475 | $11 |
| Cefuroxime | 16 | $443 | $28 |
| Amitriptyline | 19 | $386 | $20 |
| Famotidine | 44 | $368 | $8 |
| Pantoprazole | 52 | $362 | $7 |
| Isosorbide Mononitrate Er | 24 | $359 | $15 |
| Ibuprofen | 64 | $355 | $6 |
| Fenofibrate | 16 | $349 | $22 |
| Metformin | 64 | $343 | $5 |
| Tamsulosin | 16 | $339 | $21 |
| Losartan | 50 | $338 | $7 |
| Clopidogrel | 32 | $289 | $9 |
| Meloxicam | 67 | $284 | $4 |
| Montelukast | 32 | $283 | $9 |
| Furosemide | 59 | $259 | $4 |
| Cyclobenzaprine | 39 | $251 | $6 |
| Hydralazine | 14 | $219 | $16 |
| Mirtazapine | 13 | $197 | $15 |
| Naproxen | 23 | $196 | $9 |
| Carvedilol | 29 | $194 | $7 |
| Metoprolol | 37 | $187 | $5 |
| Klor-Con 10 | 12 | $180 | $15 |
| Lovastatin | 14 | $175 | $12 |
| Buspirone | 22 | $160 | $7 |
| Hydrochlorothiazide | 51 | $158 | $3 |
| Methocarbamol | 17 | $138 | $8 |
| Triamcinolone Acetonide | 24 | $137 | $6 |
| Amoxicillin | 30 | $117 | $4 |
| Amoxicillin-Clavulanate Potass | 15 | $112 | $7 |
| Norgestimate-Ethinyl Estradiol | 11 | $112 | $10 |
| Ciprofloxacin | 25 | $106 | $4 |
| Lisinopril-Hydrochlorothiazide | 12 | $103 | $9 |
| Cephalexin | 13 | $102 | $8 |
| Quetiapine | 12 | $96 | $8 |
| Meclizine | 13 | $86 | $7 |
| Citalopram Hbr | 12 | $85 | $7 |
| Topiramate | 11 | $65 | $6 |
Money from drug and device companies
$23 in 2023
A payment is not proof that care is biased.
| GlaxoSmithKline | Arexvy | $23 | 1 payment
|
See the published payment
| GlaxoSmithKline | Meals · 2023-07-12 | Arexvy | $23 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1841694189
- Licence
- CA 95017140, MI 4704254186
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X); Federal specialty code 363LP2300X (363LP2300X)
- Mailing address
- 2084 Calle Mesa Alta, Milpitas, CA, 95035
- NPI first listed
- 2014-10-15
- NPI last updated
- 2022-03-14
- NPI record certified
- 2022-03-14
This is when the NPI record was last certified, not a medical board exam.